Compass Pathways Saham

Compass Pathways DSCR

Rasio Cakupan Layanan Hutang (DSCR) dari Compass Pathways (CMPS) pada 11 Agu 2026.

DSCR

0,00

Terakhir Diperbarui:

Rasio Cakupan Layanan Hutang (DSCR) dari Compass Pathways adalah 2026 0,00 . Rasio Cakupan Layanan Hutang (DSCR) dari Compass Pathways adalah 2025 -3,95 . Menurun % lebih tinggi dibandingkan dengan tahun sebelumnya.
Access this data via the Eulerpool API

Compass Pathways Analisis saham

Apa yang dilakukan Compass Pathways? Compass Pathways PLC is a leading company specializing in the development of groundbreaking therapies for the treatment of mental illnesses. The company was founded in 2016 and is headquartered in London. Its goal is to revolutionize the treatment of depression and other mental illnesses. The business model of Compass Pathways is based on researching psychedelics as a potential treatment for patients suffering from severe depression and anxiety disorders. The company uses innovative approaches to precisely study the effects of psychedelics on the human brain and develop new therapy concepts and products from that. An important area of Compass Pathways is clinical research. The company collaborates closely with leading research institutions to understand the impacts of psychedelics on the human brain. The research results are then used to develop innovative methods for therapeutic use of psychedelics. Another important area of Compass Pathways is the development of therapeutic products. The company has developed a patented process for producing psilocybin, a substance found in hallucinogenic mushrooms. This process achieves a very high purity of the substance, enabling precise dosing and better control of its effects. The flagship product of Compass Pathways is COMP360, a medication based on psilocybin that is being developed for the treatment of depression. The medication is currently in clinical Phase 2 trials, showing promising results. If COMP360 receives approval, it has the potential to drastically change the way we treat depression. Compass Pathways is also active in other areas. The company conducts a range of research projects related to various psychedelic substances, including LSD and other hallucinogens. Another important area of Compass Pathways is training therapists and other professionals in the use of psychedelic substances. The company offers relevant courses to promote understanding of the therapeutic use of psychedelics and enable their safe and effective application for patient treatment. Overall, Compass Pathways is a company focused on the development of groundbreaking therapies for mental illnesses. Through combining cutting-edge research, innovative products, and professional education, the company has the potential to revolutionize the way we treat mental illnesses. Compass Pathways adalah salah satu perusahaan paling populer di Eulerpool.

Pertanyaan yang Sering Diajukan tentang saham Compass Pathways

Di Eulerpool Anda dapat menemukan perkembangan historis lengkap Rasio Cakupan Layanan Hutang (DSCR) Compass Pathways sejak 2006 – dengan nilai tahunan, bagan, dan analisis detail.

DSCR mengukur kemampuan perusahaan untuk memenuhi kewajiban hutangnya dari laba operasional. Rasio di atas 1,0 menunjukkan pendapatan yang cukup untuk menutupi pembayaran hutang.

Nilai '' yang 'baik' bervariasi menurut industri dan tahap perusahaan. Di Eulerpool, Anda dapat membandingkan Compass Pathways Rasio Cakupan Layanan Hutang (DSCR) dengan pesaing sektor dan rata-rata industri untuk menilai apakah menarik.

Access this data via the Eulerpool API

Leverage — Compass Pathways

Semua Metrik Kunci — Compass Pathways